BGI Genomics Co., Ltd. (SHE:300676)

China flag China · Delayed Price · Currency is CNY
40.28
-0.94 (-2.28%)
Apr 28, 2026, 3:04 PM CST
Market Cap15.82B -21.8%
Revenue (ttm)3.84B +3.4%
Net Income-573.48M
EPS-1.37
Shares Out383.85M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume6,600,188
Average Volume4,922,936
Open39.04
Previous Close41.22
Day's Range39.04 - 41.54
52-Week Range38.17 - 65.00
Beta0.86
RSI48.24
Earnings DateApr 25, 2026

About BGI Genomics

BGI Genomics Co., Ltd. engages in the provision of genomic sequencing services and proteomic services to academic institutions, pharmaceutical companies, health care providers and other organizations in China and internationally. The company offers DNA sequencing services covering whole genome sequencing, plant/animal whole genome sequencing, exome sequencing, de novo sequencing, and metagenomic sequencing; and mass spectrometry services, such as proteomic services and biologics characterization services. It also provides diagnostics and precis... [Read more]

Sector Healthcare
Founded 1999
Employees 3,580
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 300676
Full Company Profile

Financial Performance

In 2025, BGI Genomics's revenue was 3.71 billion, a decrease of -4.18% compared to the previous year's 3.87 billion. Losses were -616.66 million, -31.69% less than in 2024.

Financial Statements